UNICYCIVE THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 14.17 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-11-12
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 14.17M shares, a 66.40% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 8.77M shares, a 3.39% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 8.51M shares.
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 8.48M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month |
|---|---|---|---|
| 2021-09-30 | 14.17M shares 10-Q · filed 2021-11-12 | 11.47M shares derived: average of 2 quarters · filed 2021-11-12 | 10.54M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 8.77M shares 10-Q · filed 2021-08-16 | 8.68M shares 10-Q · filed 2021-08-16 | |
| 2020-09-30 | 8.51M shares 10-Q · filed 2021-11-12 | 8.50M shares derived: average of 2 quarters · filed 2021-11-12 | 8.49M shares 10-Q · filed 2021-11-12 |
| 2020-06-30 | 8.48M shares 10-Q · filed 2021-08-16 | 8.47M shares 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |